He is a supply chain consultant specialising in supply chain dynamics and is founder and Executive Director of Pharma TEAM-UP, a non-profit initiative with the goal of fostering closer supply chain integration. He is one of the principal architects behind the Poseidon program, which has been conceived to radically transform the transportation of pharmaceutical products by sea. This is being achieved through the application of contemporary supply chain best-practice and structured, multi-party collaboration.
Sorry there was an error sending your form. A year veteran of Schering-Plough, Mr.
Close Robert Wild, Ph. Throughout his career, Dr. Wild has contributed to the advancement of numerous clinical development candidates, including four FDA-approved oncology therapeutics sunitinib, cetuximab, dasatinib and erlotinib.
Before Dracen Pharmaceuticals, Dr. Wild functioned as an independent consultant to biotech, pharma and venture capital companies.
Wild is a native of Germany and received his undergraduate and graduate degrees at the University of Minnesota, Minneapolis. Bilski joined Dracen in with more than 20 years of experience in accounting, finance, strategic planning, and executive management for public and private companies.
Prior to joining Tragara, Mr. Bilski played a key role in leading DMD through a turnaround and rapid expansion and subsequent acquisition by Fiserv, Inc.
Prior to DMD, Mr. Bilski also spent two years with a consulting firm, where he worked exclusively with early-stage technology firms. Close Mohamed Ragab, M. Ragab was most recently the Vice President, Search and Evaluation, Oncology at Bristol-Myers Squibb where he was involved in many major immune-oncology deals.
Close Margaret Dugan, M.
She led the Novartis Exploratory Oncology Development Group for 5 years which transitioned compounds from discovery to proof-of-concept in the clinic, including Tasigna. Dugan received her BA and medical degrees and training in hematology and oncology from New York University.
As a Partner on the Biotech team at Deerfield since and the Chief Science Officer sinceBob provides extensive research and analysis on individual companies operating in the healthcare industry.
Prior to joining Deerfield, Bob was a healthcare analyst at Janus Capital from to Previously, he founded and managed a group ophthalmology practice. Bob earned his undergraduate degree at Rollins College and his medical degree at West Virginia University.
He earned an M. Jackson is also a CFA charterholder. Pardoll attended Johns Hopkins University, where he earned his M.
Pardoll joined the departments of oncology and medicine in Pardoll has published over papers as well as over 20 book chapters on the subject of T cell immunology and cancer vaccines.Featured Supply Chain articles page, from SCDigest is the industry's best publication and web site for supply chain management and logistics practioners to find information, news, insight, education, opinion and tools.
We cover supply chain, logistics, distribution, RFID, material handling, transportation, supply chain software, manufacturing, supply chain strategy and much more. The South Africa AIDS Controversy A Case Study in Patent Law and Policy Prof. William W. Fisher III % are of mixed race, and % are Indian.
Fifty percent of the population the pharmaceutical industry and the World Health Organization (WHO), the.
about us dracen is a privately-funded biotech company developing drugs in the area of immuno-metabolism. targeting immuno-metabolism promises to have broad acting effects on modulating immune responses in multiple disease settings.
Ulcerative colitis is a chronic inflammatory bowel disease characterized by symptoms of bloody diarrhea, abdominal cramps, and fatigue. 1 Current medical therapy has important limitations.
General Information: On March 8, , the below debtor (the "Debtor") filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code (the "Bankruptcy Code").
"He may be a son-of-a-bitch, but he's our son-of-a-bitch" – this is what U.S. President Franklin Roosevelt is rumoured to have once said about Nicaraguan dictator Anastasio Somoza. We examine how the western media, always so full of editorials and columns praising western values (whatever those may be), have covered.